Search | Page 2 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Discontinuation of hypomethylating agent therapy in patients with myelodysplastic syndromes or acute myelogenous leukemia in complete remission or partial response: Retrospective analysis of survival after long-term follow-up

    ... patients with myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) until treatment failure. However, the outcomes for patients who ...

    Research Article last updated 05/26/2015 - 12:53pm.

  2. Aplastic Anemia and MDS International Foundation (AAMDSIF): Bone marrow failure disease scientific symposium 2016

    ... blood cytopenias and, sometimes, progression to acute myelogenous leukemia . Research efforts have been made all over the world to ...

    Research Article last updated 01/24/2017 - 11:54am.

  3. Phase I trial of sodium salicylate in patients with myelodysplastic syndromes and acute myelogenous leukemia

    Journal Title:  Leuk Res Primary Author:  Klimek VM Author(s):  Klimek VM, Do...

    Research Article last updated 01/09/2012 - 2:21pm.

  4. Resources to Help

    ... assistance for Myelodysplastic Syndromes (MDS), Acute Myeloid Leaukemia (AML), Acute Lymphoblastic Leukemia (ALL), ... (800) 366-7741 Offers help to patients with chronic myelogenous leukemia and PNH (through their Complement Mediated Disease (CMD) ...

    Topic section last updated 02/22/2018 - 9:51am.

  5. Molecular Testing in Patients with Suspected Myelodysplastic Syndromes

    ... and with a propensity to transform to acute myelogenous leukemia . Newer technologies such as next-generation sequencing have ...

    Research Article last updated 11/02/2016 - 10:09am.

  6. Top expert calls future MDS/AML care “promising”

    ... paradigms for myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), researchers predict that hypomethylating agents, ... diseases—myelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML). I focused more on MDS because it’s my primary ...

    Article last updated 11/02/2016 - 11:28am.

  7. Can G-CSF Cause Leukemia in Hematopoietic Stem Cell Donors?

    ... later development of myelodysplastic syndromes / acute myelogenous leukemia (MDS/AML) in several clinical circumstances. Although ...

    Research Article last updated 10/11/2011 - 5:58pm.

  8. Myelodysplastic syndromes with 5q deletion: pathophysiology and role of lenalidomide

    ... hematopoiesis , often transforming into acute myelogenous leukemia (AML). A subset of patients has 5q deletion (del(5q)) ...

    Research Article last updated 04/17/2014 - 11:29am.

  9. Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management

    ... cytopenias and increased risk of transformation to acute myelogenous leukemia (AML). MDS occurs more frequently in older male and ...

    Research Article last updated 02/04/2014 - 1:37pm.

  10. The myelodysplastic syndrome as a prototypical epigenetic disease.

    ... balance and result in the development of acute myelogenous leukemia . Although MDS is clinically and physiologically heterogeneous, a ...

    Research Article last updated 08/30/2013 - 2:12pm.